Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Lenalidomide
×
Myeloid
×
Clear all
Filters
3
NCT04036448
2025-03-11
RevlimidPMS
Celgene
Completed
28 enrolled
NCT01953692
2021-08-04
MK-3475-013
Merck Sharp & Dohme LLC
Phase 1
Completed
197 enrolled
52 charts